Shyft Score
Directory quality rating
Our take
Request a demo to evaluate FidoCure® for your team.
See how FidoCure® fits your stackBenefits
Reduce trial-and-error treatment approaches with genomically-guided therapy selection
Monitor treatment effectiveness in real-time to adjust protocols quickly
Access specialized oncology expertise through our veterinary network
Provide pet owners with clear, actionable treatment insights through an intuitive dashboard
About
FidoCure uses genomic testing to create personalized cancer treatment plans for dogs. Veterinarians access treatment recommendations, monitoring dashboards, and a network of oncology specialists to manage each dog's care.
Personalized treatment plans for canine cancer
Comprehensive genomic testing
Real-time monitoring of treatment efficacy
User-friendly dashboard for pet owners and veterinarians
Access to a network of veterinary oncologists
Use cases
Diagnose and treat canine cancer using FidoCure's precision medicine approach and genetic testing.
Access personalized treatment plans for canine cancer patients based on their unique genetic profile.
Monitor and manage canine cancer treatment progress using FidoCure's online portal and support tools.
Best for
Pricing
FidoCure® starts at $99/mo
Starting at $99/mo
Ecosystem
MCP servers, AI skills, and integrations that work with FidoCure®
FAQs
Common questions about FidoCure® and its capabilities
FidoCure® is a subscription-based B2B tool providing precision medicine for canine oncology. It offers personalized treatment plans, comprehensive genomic testing, and real-time efficacy monitoring, empowering veterinarians specializing in oncology to deliver advanced, data-driven care and improve outcomes for their canine patients.
Our team can help you integrate FidoCure® with your existing tools and build custom automation workflows.
Pulse delivers operations-specific AI insights every week. Free.
Explore
Alternatives, related tools, and resources for FidoCure®
Our free scan analyzes your website, detects your tools, and shows gaps in your AI readiness.